302 related articles for article (PubMed ID: 28667294)
41. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
42. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
[TBL] [Abstract][Full Text] [Related]
43. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
44. miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.
Zhang Y; Dai J; Deng H; Wan H; Liu M; Wang J; Li S; Li X; Tang H
Br J Cancer; 2015 Jan; 112(2):365-74. PubMed ID: 25422913
[TBL] [Abstract][Full Text] [Related]
45. Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma.
Wan Y; Cui R; Gu J; Zhang X; Xiang X; Liu C; Qu K; Lin T
Oxid Med Cell Longev; 2017; 2017():5189138. PubMed ID: 28811864
[TBL] [Abstract][Full Text] [Related]
46. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
[TBL] [Abstract][Full Text] [Related]
47. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
Li L; Yuan L; Luo J; Gao J; Guo J; Xie X
Clin Exp Med; 2013 May; 13(2):109-17. PubMed ID: 22623155
[TBL] [Abstract][Full Text] [Related]
48. miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma.
Wu G; Li Z; Wang Y; Ju X; Huang R
Biomed Res Int; 2018; 2018():2863902. PubMed ID: 30627547
[TBL] [Abstract][Full Text] [Related]
49. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
[TBL] [Abstract][Full Text] [Related]
50. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-34a promotes MICB expression in hepatocytes.
Zhou MT; Zhao C; Chen X; Zhang HC; Li G; Lou H; Huang WJ; Wei LJ; Li DW; Wu X; Zhang ZC; Liu H; Ou R; Yang WJ; Hu S; Xu Y; Tang KF
Carcinogenesis; 2018 Dec; 39(12):1477-1487. PubMed ID: 30256916
[TBL] [Abstract][Full Text] [Related]
52. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
[TBL] [Abstract][Full Text] [Related]
53. Expression and role of SIRT1 in hepatocellular carcinoma.
Choi HN; Bae JS; Jamiyandorj U; Noh SJ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2011 Aug; 26(2):503-10. PubMed ID: 21567102
[TBL] [Abstract][Full Text] [Related]
54. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
[TBL] [Abstract][Full Text] [Related]
55. Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model.
Reynolds RH; Petersen MH; Willert CW; Heinrich M; Nymann N; Dall M; Treebak JT; Björkqvist M; Silahtaroglu A; Hasholt L; Nørremølle A
Mol Cell Neurosci; 2018 Apr; 88():118-129. PubMed ID: 29289683
[TBL] [Abstract][Full Text] [Related]
56. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.
Hu Z; Fan H; Lv G; Zhou Q; Yang B; Zheng J; Cao W
J Dermatol Sci; 2015 Aug; 79(2):155-62. PubMed ID: 25982144
[TBL] [Abstract][Full Text] [Related]
57. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
58. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
[TBL] [Abstract][Full Text] [Related]
59. The miR-34a-5p-c-MYC-CHK1/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response.
Zhao X; Zhuang Y; Wang B; Yuan B; Du S; Zeng Z
Radiat Res; 2023 Jan; 199(1):48-60. PubMed ID: 36445955
[TBL] [Abstract][Full Text] [Related]
60. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
